SCHEMBL15575996

SCHEMBL15575996

COc1ccc(-c2nnc(Nc3nc4c(OC)cccc4s3)o2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 1.00
KDM4E B2RXH2 9/20 1.00
HPGD P15428 9/20 1.00
MAPT P10636 9/20 1.00
DUSP3 P51452 8/20 1.00
HSD17B10 Q99714 8/20 1.00
TP53 P04637 7/20 1.00
POLB P06746 3/20 1.00
HTT P42858 3/20 1.00
PTPN7 P35236 2/20 1.00
TSHR P16473 1/20 1.00
BLM P54132 1/20 1.00
PTK2B Q14289 1/20 1.00
EIF4H Q15056 1/20 1.00
TDP1 Q9NUW8 7/20 0.84
LMNA P02545 7/20 0.84
MEN1 O00255 7/20 0.84
KMT2A Q03164 7/20 0.84
ESR1 P03372 1/20 0.84
PTPN2 P17706 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15617087 0.92 ALDH1A1 (0.85) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL15575443 0.91 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL30065644 0.91 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL15617100 0.91 ALDH1A1 (0.84) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL15617091 0.90 ALDH1A1 (0.82) ALDH1A1KDM4EHPGDMAPTDUSP3
Hydrochloric Acid SCHEMBL29921361 0.90 ALDH1A1 (0.98) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL20660703 0.90 ALDH1A1 (0.82) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL15617108 0.90 MAPT (0.82) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL15617089 0.90 ALDH1A1 (0.81) ALDH1A1KDM4EHPGDMAPTDUSP3
SCHEMBL15617119 0.89 ALDH1A1 (0.79) ALDH1A1KDM4EHPGDMAPTDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3302522-B1 MEANS AND METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD). ACADEMISCH ZIEKENHUIS LEIDEN (NL) 2022-08-31 EP claimed
EP-2890379-B1 BENZOTHIAZOLE OR BENZOXAZOLE COMPOUNDS AS SUMO ACTIVATORS ICAHN SCHOOL MED MOUNT SINAI (US) 2019-04-03 EP claimed
US-20180127407-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators ICAHN SCHOOL MED MOUNT SINAI (US) 2018-05-10 US claimed
US-20150218148-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators ICAHN SCHOOL MED MOUNT SINAI (US) 2015-08-06 US claimed
EP-2890379-A2 BENZOTHIAZOLE OR BENZOXAZOLE COMPOUNDS AS SUMO ACTIVATORS Icahn School of Medicine at Mount Sinai (US) 2015-07-08 EP claimed
WO-2014036242-A2 BENZOTHIAZOLE OR BENZOXAZOLE COMPOUNDS AS SUMO ACTIVATORS MOUNT SINAI SCHOOL OF MEDICINE (US) 2014-03-06 WO claimed
CN-116549487-A Method for inducing G1/S-specific cyclin-D1 type ubiquitination, application and preparation 深圳先进技术研究院 2023-08-08 CN disclosed
WO-2023070815-A1 METHOD FOR INDUCING SUMOYLATION OF G1/S-SPECIFIC CYCLIN-D1, USE AND PREPARATION 深圳先进技术研究院 2023-05-04 WO disclosed
WO-2023070815-A1 METHOD FOR INDUCING SUMOYLATION OF G1/S-SPECIFIC CYCLIN-D1, USE AND PREPARATION 深圳先进技术研究院 2023-05-04 WO disclosed
EP-3302522-B1 MEANS AND METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD). ACADEMISCH ZIEKENHUIS LEIDEN (NL) 2022-08-31 EP disclosed
CN-114181317-A Method for inducing G1/S-specific cyclin-D1 ubiquitination, application and preparation 深圳先进技术研究院 2022-03-15 CN disclosed
US-20200270240-A1 BENZOTHIAZOLE AND PYRIDOTHIAZOLE COMPOUNDS AS SUMO ACTIVATORS ICAHN SCHOOL MED MOUNT SINAI (US) 2020-08-27 US disclosed
US-20200270240-A1 BENZOTHIAZOLE AND PYRIDOTHIAZOLE COMPOUNDS AS SUMO ACTIVATORS ICAHN SCHOOL MED MOUNT SINAI (US) 2020-08-27 US disclosed
WO-2016195493-A1 MEANS AND METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD). ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC (NL) 2016-12-08 WO disclosed
US-20150218148-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators ICAHN SCHOOL MED MOUNT SINAI (US) 2015-08-06 US disclosed
US-20150218148-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators ICAHN SCHOOL MED MOUNT SINAI (US) 2015-08-06 US disclosed
US-20150218148-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators ICAHN SCHOOL MED MOUNT SINAI (US) 2015-08-06 US disclosed
EP-2890379-A2 BENZOTHIAZOLE OR BENZOXAZOLE COMPOUNDS AS SUMO ACTIVATORS Icahn School of Medicine at Mount Sinai (US) 2015-07-08 EP disclosed
WO-2014036242-A2 BENZOTHIAZOLE OR BENZOXAZOLE COMPOUNDS AS SUMO ACTIVATORS MOUNT SINAI SCHOOL OF MEDICINE (US) 2014-03-06 WO disclosed
WO-2014036242-A2 BENZOTHIAZOLE OR BENZOXAZOLE COMPOUNDS AS SUMO ACTIVATORS MOUNT SINAI SCHOOL OF MEDICINE (US) 2014-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218148-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators SUMO2, UBA2, SUMO1 ALDH1A1 3054/4885KDM4E 1851/4885HPGD 4321/4885
US-20200270240-A1 BENZOTHIAZOLE AND PYRIDOTHIAZOLE COMPOUNDS AS SUMO ACTIVATORS SUMO2, ATP2A2, ATP2A1 ALDH1A1 3082/4885KDM4E 1821/4885HPGD 3822/4885
US-20180127407-A1 Benzothiazole Or Benzoxazole Compounds As Sumo Activators SUMO2, UBA2, SUMO1 ALDH1A1 3054/4885KDM4E 1851/4885HPGD 4321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.